Showing results (241-250 of 444) with videos related to

Sort By:
Pageof 45
Respiration; International Review of Thoracic Diseases|May 5, 2017
Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging TherapiesDaniele Magnini, Giuliano Montemurro, Bruno Iovene, et al.
Journal of Clinical Medicine|November 27, 2021
The Use of Chitotriosidase as a Marker of Active Sarcoidosis and in the Diagnosis of Fever of Unknown Origin (FUO)Angela Maria Di Francesco, Elena Verrecchia, Ludovico Luca Sicignano, et al.
BMC Pulmonary Medicine|September 22, 2020
Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: relationships with disease progression and pulmonary function trendsGiacomo Sgalla, Anna Rita Larici, Nicoletta Golfi, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Obstructive sleep apnea in sarcoidosis and impact of cpap treatment on fatiguePier-Valerio Mari, Giuliana Pasciuto, Matteo Siciliano, et al.
Current Neuropharmacology|December 31, 2020
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative StressGanesh Raghu, Michael Berk, Peter A Campochiaro, et al.
AIDS (London, England)|July 11, 2003
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patientsMilena Nasi, Vanni Borghi, Marcello Pinti, et al.
Expert Opinion on Investigational Drugs|August 5, 2017
Investigational drugs for idiopathic pulmonary fibrosisFrancesco Varone, Giuliano Montemurro, Francesco Macagno, et al.
The Journal of Infection|December 26, 2006
Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practiceSarah Gooding, Oni Chowdhury, Tim Hinks, et al.
Respiratory Medicine|February 27, 2016
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trialsLuca Richeldi, Vincent Cottin, Roland M du Bois, et al.
Cureus|September 13, 2021
Fatality Rate and Survival Time of Laboratory-Confirmed COVID-19 for Patients in England During the First Wave of SARS-CoV-2 Infection: A Modelling StudyChristopher R Hillyar, Anjan Nibber, Christine E Jones, et al.
Pageof 45